MYL2 Antibodies

Santa Cruz Biotechnology delivers a wide array of MYL2 Antibodies for research in muscle biology and cardiac function. MYL2 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MYL2, or myosin light chain 2, plays a critical role in muscle contraction and is essential for the proper functioning of cardiac and skeletal muscle tissues. Abnormalities in MYL2 expression or function can lead to various cardiac diseases, making it a significant target for research in cardiovascular health. Understanding MYL2 in muscle physiology can provide insights into potential therapeutic strategies for heart-related conditions. Research focused on MYL2 continues to reveal new aspects of muscle development and regulation. Investigating MYL2's molecular mechanisms helps advance knowledge in cardiovascular medicine. Santa CruzBiotechnology monoclonal antibodies enable researchers worldwide to make meaningful contributions to muscle biology and cardiac research.